LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 161 filers reported holding LEGEND BIOTECH CORP in Q1 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $15,718 | -18.7% | 234 | -16.4% | 0.00% | 0.0% |
| Q2 2023 | $19,328 | +6.3% | 280 | -25.7% | 0.00% | 0.0% |
| Q1 2023 | $18,179 | -13.9% | 377 | -10.9% | 0.00% | -25.0% |
| Q4 2022 | $21,116 | +50.8% | 423 | +22.3% | 0.00% | +33.3% |
| Q3 2022 | $14,000 | -26.3% | 346 | 0.0% | 0.00% | -25.0% |
| Q2 2022 | $19,000 | +111.1% | 346 | +43.6% | 0.00% | +100.0% |
| Q1 2022 | $9,000 | -55.0% | 241 | -42.6% | 0.00% | -50.0% |
| Q4 2021 | $20,000 | – | 420 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 1,629,173 | $66,470,000 | 19.56% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,466,453 | $59,831,000 | 8.69% |
| Paradigm Biocapital Advisors LP | 1,076,591 | $43,925,000 | 5.86% |
| HHLR ADVISORS, LTD. | 5,136,617 | $209,574,000 | 5.51% |
| RA Capital Management | 2,338,610 | $95,415,000 | 2.04% |
| Nicholas Investment Partners, LP | 399,486 | $16,299,000 | 1.51% |
| Parkman Healthcare Partners LLC | 121,227 | $4,946,000 | 1.41% |
| Capital International, Inc./CA/ | 1,244,362 | $50,770,000 | 1.13% |
| AtonRa Partners | 28,150 | $1,149,000 | 1.13% |
| Vivo Capital, LLC | 244,375 | $9,971,000 | 1.10% |